Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin
Enliven Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.2%)
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Patel Anish
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kintz Samuel
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyssikatos Joseph P
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Heyman Richard A.
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collins Helen Louise
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Heyman Richard A.
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyssikatos Joseph P
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kintz Samuel
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ballal Rahul D.
No Data
No Data